Literature DB >> 15669929

Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.

Pamela N Schultz1, Mary Jean Klein, Martha L Beck, Charles Stava, Rena V Sellin.   

Abstract

AIMS AND
OBJECTIVES: The purpose of this study is to describe the relationship between menopausal symptoms, physiologic health effects of cancer treatment and the physical contributors to quality of life in long-term survivors of breast cancer.
BACKGROUND: The treatment of menopausal symptoms is hotly debated, especially for women with breast cancer. Common treatments for menopausal symptoms are considered to be contraindicated in women with breast cancer.
DESIGN: This is a descriptive, cross-sectional study of long-term breast cancer survivors; a subset of a study that responded to a mailed survey targeting long-term cancer survivors treated at The University of Texas M.D. Anderson Cancer Center.
METHODS: In 291 breast cancer patients information was available that included items that commonly relate to menopausal symptoms including hot flushes, painful sexual intercourse, inability to concentrate, fatigue and sleep disturbances.
RESULTS: Ninety per cent were Caucasian American and the mean time since diagnosis was 16 +/- 8 years. All patients had been treated with surgery, (60%) with radiotherapy, (68%) with chemotherapy and (37%) with hormonal therapy. Forty-six per cent of the breast cancer survivors indicated that having breast cancer affected their overall health. Self-reported health effects were more common in those survivors who had received a combination of chemotherapy and radiotherapy. A menopausal quality of life score was determined using the items about hot flushes, ability to concentrate, painful sexual intercourse, fatigue, unhappiness and sleep disturbances.
CONCLUSIONS: This study reminds us that breast cancer and menopause are independent issues. Quality of life parameters need to be rigidly defined and time sensitive. There are complex interactions between quality of life indicators and specific physiologic consequences of treatment. However, menopausal signs and symptoms may not be different for the breast cancer survivor and they should not be confused with the quality of life/psychosocial issues of the cancer survivor. RELEVANCE TO CLINICAL PRACTICE: Menopause is not a disease process but a normal developmental stage for women. It is important for nurses not only to understand the client needs of the menopausal woman, but also to be able to differentiate between quality of life issues related to menopause and to cancer treatment in order to provide holistic nursing care.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15669929     DOI: 10.1111/j.1365-2702.2004.01030.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  32 in total

Review 1.  Impact on quality of life of adjuvant therapy for breast cancer.

Authors:  Halle C F Moore
Journal:  Curr Oncol Rep       Date:  2007-01       Impact factor: 5.075

2.  Yoga as Treatment for Insomnia Among Cancer Patients and Survivors: A Systematic Review.

Authors:  Karen M Mustian
Journal:  Eur Med J Oncol       Date:  2013-11-01

3.  Symptom clusters and quality of life in older adult breast cancer survivors.

Authors:  Rachel A Roiland; Susan M Heidrich
Journal:  Oncol Nurs Forum       Date:  2011-11       Impact factor: 2.172

Review 4.  Prevalence and risk factors of sleep disturbances in breast cancersurvivors: systematic review and meta-analyses.

Authors:  Laurence Leysen; Astrid Lahousse; Jo Nijs; Nele Adriaenssens; Olivier Mairesse; Sergei Ivakhnov; Thomas Bilterys; Eveline Van Looveren; Roselien Pas; David Beckwée
Journal:  Support Care Cancer       Date:  2019-07-25       Impact factor: 3.603

5.  Differences in depression, anxiety, and quality of life between women with and without breast pain prior to breast cancer surgery.

Authors:  Maria Kyranou; Steven M Paul; Laura B Dunn; Kathleen Puntillo; Bradley E Aouizerat; Gary Abrams; Deborah Hamolsky; Claudia West; John Neuhaus; Bruce Cooper; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2012-08-11       Impact factor: 2.398

6.  Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541.

Authors:  Electra Paskett; James Herndon; Kathleen Donohue; Michelle Naughton; Stephen Grubbs; Michael Pavy; Martee Hensley; Nancy Stark; Alice Kornblith; Marisa Bittoni
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

7.  Correlation between hemoglobin and fatigue in women undergoing adjuvant chemotherapy without erythropoietin-stimulating-agent support.

Authors:  Sarah Blair; Wayne A Bardwell; Yaffa Podbelewicz-Schuller; Joanne E Mortimer
Journal:  Clin Breast Cancer       Date:  2008-12       Impact factor: 3.225

8.  The Management of Menopausal Symptoms in Women Following Breast Cancer: An Overview.

Authors:  Cheryl Phua; Rodney Baber
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

9.  Prevalence, severity, and correlates of sleep-wake disturbances in long-term breast cancer survivors.

Authors:  Julie L Otte; Janet S Carpenter; Kathleen M Russell; Silvia Bigatti; Victoria L Champion
Journal:  J Pain Symptom Manage       Date:  2010-01-18       Impact factor: 3.612

10.  Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer.

Authors:  Kavita D Chandwani; Charles E Heckler; Supriya G Mohile; Karen M Mustian; Michelle Janelsins; Luke J Peppone; Peter Bushunow; Patrick J Flynn; Gary R Morrow
Journal:  Explore (NY)       Date:  2014-04-18       Impact factor: 1.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.